Aspen Pharmacare said Mylan NV exercised an option to buy the South African drugmaker’s portfolio of prescription and over-the-counter products in Australia for 188 million Australian dollars ($130 million).
The Australian subsidiaries of British drugmaker GlaxoSmithKline and Swiss drugmaker Novartis misled customers and broke the law by promoting identical liniments as though they could treat specific ills, an Australian court found.
Global pharma giant AstraZeneca (AZN) employed a man in Australia who allegedly falsified his credentials to pose as a doctor, according to reports from the Australian Broadcast Company. Shyam Acharya […]
